The 22q13.3 Deletion Syndrome (Phelan-McDermid Syndrome) - PubMed (original) (raw)
. 2012 Apr;2(3-5):186-201.
doi: 10.1159/000334260. Epub 2011 Nov 22.
Affiliations
- PMID: 22670140
- PMCID: PMC3366702
- DOI: 10.1159/000334260
The 22q13.3 Deletion Syndrome (Phelan-McDermid Syndrome)
K Phelan et al. Mol Syndromol. 2012 Apr.
Abstract
The 22q13.3 deletion syndrome, also known as Phelan-McDermid syndrome, is a contiguous gene disorder resulting from deletion of the distal long arm of chromosome 22. In addition to normal growth and a constellation of minor dysmorphic features, this syndrome is characterized by neurological deficits which include global developmental delay, moderate to severe intellectual impairment, absent or severely delayed speech, and neonatal hypotonia. In addition, more than 50% of patients show autism or autistic-like behavior, and therefore it can be classified as a syndromic form of autism spectrum disorders (ASD). The differential diagnosis includes Angelman syndrome, velocardiofacial syndrome, fragile X syndrome, and FG syndrome. Over 600 cases of 22q13.3 deletion syndrome have been documented. Most are terminal deletions of ∼100 kb to >9 Mb, resulting from simple deletions, ring chromosomes, and unbalanced translocations. Almost all of these deletions include the gene SHANK3 which encodes a scaffold protein in the postsynaptic densities of excitatory synapses, connecting membrane-bound receptors to the actin cytoskeleton. Two mouse knockout models and cell culture experiments show that SHANK3 is involved in the structure and function of synapses and support the hypothesis that the majority of 22q13.3 deletion syndrome neurological defects are due to haploinsufficiency of SHANK3, although other genes in the region may also play a role in the syndrome. The molecular connection to ASD suggests that potential future treatments may involve modulation of metabotropic glutamate receptors.
Figures
Fig. 1
These patients with 22q13.3 deletion syndrome demonstrate the wide differences in facial phenotype that may make clinical diagnosis difficult. Many children will have facial hypotonia, mild periorbital fullness, long eyelashes, full cheeks, and smoothing of the philtrum.
Fig. 2
Dysplastic toenails. A Small and poorly formed toenails of a 3-year-old child. B Jagged and thick toenails of an 11-year-old girl. Toenails were small and thin during early childhood, then became thicker with a tendency to become ingrown.
Fig. 3
SHANK3 structure and function. A Genomic structure of SHANK3. Alternatively spliced exons are marked with an asterisk. The locations of protein motifs are shown above the gene. The breakpoint hotspot consists of a complex microsatellite (D22S163) and is the location of at least 3 independent deletion breakpoints. ‘Sequence uncertainty’ refers to a small stretch of sequence not included in the Hg19 reference sequence, resulting in the incorrect annotation of an additional exon. B A representation of some of the PSD proteins that bind to SHANK3 which acts as a PSD scaffold. SHANK3 binds to various membrane-bound receptors through Homer, SAPAP, and PSD-95 proteins. SHANK3 connects to the actin cytoskeleton through proteins such as α-Fodrin and Cortactin. Two or more SHANK3 proteins can multimerize through the SAM domains [based on Kreienkamp, 2008].
Similar articles
- Interstitial 22q13 deletions not involving SHANK3 gene: a new contiguous gene syndrome.
Disciglio V, Lo Rizzo C, Mencarelli MA, Mucciolo M, Marozza A, Di Marco C, Massarelli A, Canocchi V, Baldassarri M, Ndoni E, Frullanti E, Amabile S, Anderlid BM, Metcalfe K, Le Caignec C, David A, Fryer A, Boute O, Joris A, Greco D, Pecile V, Battini R, Novelli A, Fichera M, Romano C, Mari F, Renieri A. Disciglio V, et al. Am J Med Genet A. 2014 Jul;164A(7):1666-76. doi: 10.1002/ajmg.a.36513. Epub 2014 Apr 3. Am J Med Genet A. 2014. PMID: 24700646 - A 29 Mainland Chinese cohort of patients with Phelan-McDermid syndrome: genotype-phenotype correlations and the role of SHANK3 haploinsufficiency in the important phenotypes.
Xu N, Lv H, Yang T, Du X, Sun Y, Xiao B, Fan Y, Luo X, Zhan Y, Wang L, Li F, Yu Y. Xu N, et al. Orphanet J Rare Dis. 2020 Nov 30;15(1):335. doi: 10.1186/s13023-020-01592-5. Orphanet J Rare Dis. 2020. PMID: 33256793 Free PMC article. - Deletion 22q13.3 syndrome.
Phelan MC. Phelan MC. Orphanet J Rare Dis. 2008 May 27;3:14. doi: 10.1186/1750-1172-3-14. Orphanet J Rare Dis. 2008. PMID: 18505557 Free PMC article. - Phelan McDermid Syndrome: From Genetic Discoveries to Animal Models and Treatment.
Harony-Nicolas H, De Rubeis S, Kolevzon A, Buxbaum JD. Harony-Nicolas H, et al. J Child Neurol. 2015 Dec;30(14):1861-70. doi: 10.1177/0883073815600872. Epub 2015 Sep 8. J Child Neurol. 2015. PMID: 26350728 Free PMC article. Review. - Genotype-phenotype correlation in Phelan-McDermid syndrome: A comprehensive review of chromosome 22q13 deleted genes.
Ricciardello A, Tomaiuolo P, Persico AM. Ricciardello A, et al. Am J Med Genet A. 2021 Jul;185(7):2211-2233. doi: 10.1002/ajmg.a.62222. Epub 2021 May 5. Am J Med Genet A. 2021. PMID: 33949759 Free PMC article. Review.
Cited by
- Clinical, developmental and serotonemia phenotyping of a sample of 70 Italian patients with Phelan-McDermid Syndrome.
Asta L, Ricciardello A, Cucinotta F, Turriziani L, Boncoddo M, Bellomo F, Angelini J, Gnazzo M, Scandolo G, Pisanò G, Pelagatti F, Chehbani F, Camia M, Persico AM. Asta L, et al. J Neurodev Disord. 2024 Oct 3;16(1):57. doi: 10.1186/s11689-024-09572-7. J Neurodev Disord. 2024. PMID: 39363263 Free PMC article. - Phenome-wide profiling identifies genotype-phenotype associations in Phelan-McDermid syndrome using family-sourced data from an international registry.
Yin R, Wack M, Hassen-Khodja C, McDuffie MT, Bliss G, Horn EJ, Kothari C, McLarney B, Davis R, Hanson K, O'Boyle M, Betancur C, Avillach P. Yin R, et al. Mol Autism. 2024 Sep 30;15(1):40. doi: 10.1186/s13229-024-00619-z. Mol Autism. 2024. PMID: 39350236 Free PMC article. - Immune system dysfunction and inflammation in aging Shank3b mutant mice, a model of autism spectrum disorder.
Cerilli E, Dall'O GM, Chelini G, Catena B, Weinberger B, Bozzi Y, Pangrazzi L. Cerilli E, et al. Front Immunol. 2024 Sep 6;15:1447385. doi: 10.3389/fimmu.2024.1447385. eCollection 2024. Front Immunol. 2024. PMID: 39308859 Free PMC article. - The multifaceted role of mitochondria in autism spectrum disorder.
Khaliulin I, Hamoudi W, Amal H. Khaliulin I, et al. Mol Psychiatry. 2024 Sep 2. doi: 10.1038/s41380-024-02725-z. Online ahead of print. Mol Psychiatry. 2024. PMID: 39223276 Review. - Unravelling the Cerebellar Involvement in Autism Spectrum Disorders: Insights into Genetic Mechanisms and Developmental Pathways.
Guerra M, Medici V, La Sala G, Farini D. Guerra M, et al. Cells. 2024 Jul 10;13(14):1176. doi: 10.3390/cells13141176. Cells. 2024. PMID: 39056758 Free PMC article. Review.
References
- Anderlid BM, Schoumans J, Anneren G, Tapia-Paez I, Dumanski J, et al. FISH-mapping of a 100-kb terminal 22q13 deletion. Hum Genet. 2002;110:439–443. - PubMed
- Barakat AJ, Pearl PL, Acosta MT, Runkle BP. 22q13 deletion syndrome with central diabetes insipidus: a previously unreported association. Clin Dysmorphol. 2004;13:191–194. - PubMed
- Bartsch O, Schneider E, Damatova N, Weis R, Tufano M, et al. Fulminant hepatic failure requiring liver transplantation in 22q13.3 deletion syndrome. Am J Med Genet A. 2010;152A:2099–2102. - PubMed
- Bear MF, Huber KM, Warren ST. The mGluR theory of fragile X mental retardation. Trends Neurosci. 2004;27:370–377. - PubMed
- Benedict C, Hallschmid M, Schultes B, Born J, Kern W. Intranasal insulin to improve memory function in humans. Neuroendocrinology. 2007;86:136–142. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous